Fig. 4From: The accuracy of whole-body 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) in the detection of ovarian cancer relapse in patients with rising cancer antigen 125 (CA-125) levelsA 44-year-old female patient with a history of treated ovarian malignancy. Her annual CA 125 assessment was found to be elevated up to 900. Non-contrast-enhanced CT (A), PET (B) and PET/CT (C) images showed unremarkable CT with no definite suspicious nodules. Two small perihepatic peritoneal nodules with FDG avid uptake are noted (circled) along the lateral hepatic surface in the PET and PET/CT images (SUVmax:11) denoting recurrenceBack to article page